Current status and perspectives in immunotherapy for metastatic melanoma

Metastatic melanoma was the first malignancy in which immune checkpoint inhibitors demonstrated their successful efficacy. Currently, the knowledge on the interaction between the immune system and malignant disease is steadily increasing and new drugs and therapeutic strategies are overlooking in th...

詳細記述

保存先:
書誌詳細
出版年:Oncotarget
主要な著者: Marconcini, Riccardo, Spagnolo, Francesco, Stucci, Luigia Stefania, Ribero, Simone, Marra, Elena, Rosa, Francesco De, Picasso, Virginia, Di Guardo, Lorenza, Cimminiello, Carolina, Cavalieri, Stefano, Orgiano, Laura, Tanda, Enrica, Spano, Laura, Falcone, Alfredo, Queirolo, Paola
フォーマット: Artigo
言語:Inglês
出版事項: Impact Journals LLC 2018
主題:
Review
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5844761/
https://ncbi.nlm.nih.gov/pubmed/29552325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23746
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料